의약품용 유리 앰플 시장 예측(-2030년) : 제품 유형별, 유형별, 용량별, 용도별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Pharmaceutical Glass Ampoules Market is accounted for $14.8 billion in 2024 and is expected to reach $24.7 billion by 2030 growing at a CAGR of 8.9% during the forecast period. Pharmaceutical glass ampoules are small, sealed vials made from glass, used to contain and preserve liquid medications, especially for injectable purposes. These ampoules are typically made from high-quality borosilicate glass, which offers excellent chemical resistance and thermal stability, ensuring the purity and stability of the contained pharmaceutical products. The glass material prevents interaction between the drug and the container, maintaining the efficacy and safety of the medication. This is widely used in hospitals and clinical settings, pharmaceutical glass ampoules are crucial for delivering vaccines, injectable drugs, and other critical medications safely and effectively.

According to CNN and OWID, as of March 20, 2023, about 13 billion COVID-19 vaccine doses had been administered globally, with the United States accounting for almost 672 million.

Market Dynamics:

Driver:

Rising Demand for Pharmaceuticals

The growing trend towards single-dose packaging in pharmaceuticals aligns perfectly with the strengths of glass ampoules. Single-dose packaging minimizes the risk of medication contamination and ensures precise dosage administration. Glass ampoules provide a convenient and safe solution for this growing market segment. Moreover many medications, particularly those derived from biotechnology or containing delicate components, require packaging that offers superior protection against factors like moisture, air, and light degradation. Glass ampoules, with their excellent barrier properties and chemical inertness, are ideal for this sensitive drug drives the growth of the market.

Restraint:

High cost of production

Manufacturing glass ampoules involves complex processes and high-quality borosilicate glass, which can be expensive. These costs are further compounded by stringent regulatory requirements for purity and safety, necessitating advanced technology and rigorous quality control measures. As a result, the overall production costs are significantly high. Smaller pharmaceutical companies, particularly in developing regions, might struggle to afford these higher costs, limiting their ability to produce or distribute injectable medications effectively hampers the growth of the market.

Opportunity:

Eco-friendly considerations

The growing focus on sustainability presents an opportunity for the pharmaceutical glass ampoule market. Glass is a recyclable material, making it an eco-friendly alternative compared to some plastic packaging options. As consumers and healthcare institutions become more environmentally conscious, the demand for sustainable packaging solutions like glass ampoules could rise. Thus glass ampoules can be a way to showcase a commitment to environmental responsibility, potentially attracting environmentally conscious customers.

Threat:

Limited automation potential

Manufacturing glass ampoules involves intricate processes that are difficult to fully automate, relying heavily on skilled labor for precision tasks like quality control and sealing. Additionally, the lack of automation leads to slower production rates, hindering the ability to meet the growing demand for pharmaceutical products, especially during surges such as during pandemics or health crises. This inefficiency can result in supply chain disruptions and delays in the delivery of essential medications, impacting healthcare providers and patients.

Covid-19 Impact

The surge in demand for vaccines and injectable medications led to increased production of pharmaceutical glass ampoules to accommodate mass vaccination campaigns and treatment efforts. However, disruptions in global supply chains and manufacturing operations initially posed challenges, resulting in supply shortages. Additionally, heightened focus on vaccine distribution and storage requirements emphasized the importance of reliable and high-quality glass ampoules.

The straight-stem ampoules segment is expected to be the largest during the forecast period

The straight-stem ampoules is expected to be the largest during the forecast period as the demand for safer and more user-friendly packaging grows, straight-stem ampoules offer a competitive advantage for manufacturers looking to differentiate their products in the Pharmaceutical Glass Ampoules market. Their unique design and safety features can attract healthcare providers and pharmaceutical companies seeking innovative solutions.

The neutral glass ampoules segment is expected to have the highest CAGR during the forecast period

The neutral glass ampoules segment is expected to have the highest CAGR during the forecast period owing to the chemical resistance of neutral glass makes it suitable for storing a diverse range of pharmaceutical formulations, including acidic, basic, and neutral compounds. This versatility allows pharmaceutical companies to use neutral glass ampoules for various drug formulations, expanding their market applicability.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to factors such as the increasing prevalence of chronic diseases, rising demand for injectable medications, and the need for secure and reliable packaging solutions contribute to market expansion. Additionally, technological advancements in glass manufacturing processes, stringent regulatory standards, and the presence of key market players further stimulate market growth.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period as China has established a standard framework for the pharmaceutical industry. The country is increasingly focusing on the stability of pharmaceutical packaging materials during drug storage and the safety of the packaging when used. Pharmaceutical companies increasingly use glass packaging because of its durability, non-reactivity, transparency, eco-friendliness, and versatility. Additionally, glass vials are in high demand due to increasing investment and R&D in healthcare systems and rising drug spending.

Key players in the market

Some of the key players in Pharmaceutical Glass Ampoules market include AAPL Solutions Pvt. Ltd, Accu-Glass LLC, Adit Containers Private Limited, Agrado SA, Birgimefar Group, BOROSIL, CORNING INCORPORATED, Gerresheimer AG, J. Penner Corporation, Kapoor Glass India Pvt. Lt, NIPRO Corporation, Schott AG, SGD SA (SGD Pharma), Shandong Pharmaceutical Glass Co. Ltd, Sm Pack SpA, Stevanato Group SPA, Stoelzle Oberglas GmbH and Zhengchuan Pharmaceutical Packaging

Key Developments:

In April 2024, SCHOTT launches pilot projects on glass-ceramics and specialty glass for a more circular economy. The circular economy a joint challenge for policymakers and the specialty glass industry

In March 2024, Stevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill(R) Syringes and Cartridges, the facility started commercial production in Q4 2023 and houses advanced production lines developed by Stevanato Group for the production of EZ-fill(R) pre-sterilized syringes

In March 2024, Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters' Option to Purchase Additional Ordinary Shares. The total gross proceeds from the Offering, before deducting underwriting discounts and commissions

Product Types Covered:

• Straight-Stem Ampoules
• Funnel-Type Ampoules
• Bulb-Shaped Ampoules
• Score Ring Ampoules
• Open-Tip Ampoules
• Color Break Ring (CBR) Ampoules

Types Covered:

• Neutral Glass Ampoules
• Ampoules with Colored Glass
• Ampoules with Printed Markings

Capacities Covered:

• Small capacity (up to 2ml)
• Medium capacity (2ml to 6ml)
• Large capacity (more than 6ml)

Applications Covered:

• Injectable Solutions
• Lyophilized (Freeze-Dried) Drugs
• Vaccines
• Serums
• Other Applications

End Users Covered:

• Pharmaceutical Companies
• Biotechnology Companies
• Clinical Research Organizations
• Hospitals and Clinics
• Contract Manufacturing Organizations (CMOs)
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Pharmaceutical Glass Ampoules Market, By Product Type

• 5.1 Introduction
• 5.2 Straight-Stem Ampoules
• 5.3 Funnel-Type Ampoules
• 5.4 Bulb-Shaped Ampoules
• 5.5 Score Ring Ampoules
• 5.6 Open-Tip Ampoules
• 5.7 Color Break Ring (CBR) Ampoules

6 Global Pharmaceutical Glass Ampoules Market, By Type

• 6.1 Introduction
• 6.2 Neutral Glass Ampoules
• 6.3 Ampoules with Colored Glass
• 6.4 Ampoules with Printed Markings

7 Global Pharmaceutical Glass Ampoules Market, By Capacity

• 7.1 Introduction
• 7.2 Small capacity (up to 2ml)
• 7.3 Medium capacity (2ml to 6ml)
• 7.4 Large capacity (more than 6ml)

8 Global Pharmaceutical Glass Ampoules Market, By Application

• 8.1 Introduction
• 8.2 Injectable Solutions
• 8.3 Lyophilized (Freeze-Dried) Drugs
• 8.4 Vaccines
• 8.5 Serums
• 8.6 Other Applications

9 Global Pharmaceutical Glass Ampoules Market, By End User

• 9.1 Introduction
• 9.2 Pharmaceutical Companies
• 9.3 Biotechnology Companies
• 9.4 Clinical Research Organizations
• 9.5 Hospitals and Clinics
• 9.6 Contract Manufacturing Organizations (CMOs)
• 9.7 Other End Users

10 Global Pharmaceutical Glass Ampoules Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 AAPL Solutions Pvt. Ltd
• 12.2 Accu-Glass LLC
• 12.3 Adit Containers Private Limited
• 12.4 Agrado SA
• 12.5 Birgimefar Group
• 12.6 BOROSIL
• 12.7 CORNING INCORPORATED
• 12.8 Gerresheimer AG
• 12.9 J. Penner Corporation
• 12.10 Kapoor Glass India Pvt. Ltd
• 12.11 NIPRO Corporation
• 12.12 Schott AG
• 12.13 SGD SA (SGD Pharma)
• 12.14 Shandong Pharmaceutical Glass Co. Ltd
• 12.15 Sm Pack SpA
• 12.16 Stevanato Group SPA
• 12.17 Stoelzle Oberglas GmbH
• 12.18 Zhengchuan Pharmaceutical Packaging